Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of benzochalcone derivatives as selective CYP1B1 inhibitors and anticancer agents
Jinyun Dong, G. Huang, Qijing Zhang, et al.
MedChemComm (2019) Vol. 10, Iss. 9, pp. 1606-1614
Open Access | Times Cited: 24

Showing 24 citing articles:

Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
Jinyun Dong, Zuodong Qin, Weidong Zhang, et al.
Drug Resistance Updates (2020) Vol. 49, pp. 100681-100681
Closed Access | Times Cited: 201
Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation
Jinyun Dong, Xiangdong Cheng, Weidong Zhang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 13, pp. 8884-8915
Closed Access | Times Cited: 138
Chalcone: A Promising Bioactive Scaffold in Medicinal Chemistry
Gayathri Rajendran, Deepu Bhanu, Baladhandapani Aruchamy, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1250-1250
Open Access | Times Cited: 68
Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review
Jinyun Dong, Yuan Li, Can Hu, et al.
Pharmacology & Therapeutics (2023) Vol. 249, pp. 108488-108488
Closed Access | Times Cited: 58
Discovery of the Triazolo[1,5-a]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance
Shuai Wang, Saiqi Wang, Qiu‐Xu Teng, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 21, pp. 16187-16204
Closed Access | Times Cited: 24
Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors
Jinyun Dong, Zengtao Wang, Jiahua Cui, et al.
European Journal of Medicinal Chemistry (2019) Vol. 187, pp. 111938-111938
Closed Access | Times Cited: 29
Discovery of heterocycle-containing α-naphthoflavone derivatives as water-soluble, highly potent and selective CYP1B1 inhibitors
Jinyun Dong, G. Huang, Qing Cui, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112895-112895
Closed Access | Times Cited: 25
Discovery of benzochalcone derivative as a potential antigastric cancer agent targeting signal transducer and activator of transcription 3 (STAT3)
Jinyun Dong, Jing Yang, Wen-Kai Yu, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2004-2016
Open Access | Times Cited: 15
Functionalized Sulfur-Containing Heterocyclic Analogs Induce Sub-G1 Arrest and Apoptotic Cell Death of Laryngeal Carcinoma In Vitro
B. Haridevamuthu, Tamilvelan Manjunathan, Carlton Ranjith Wilson Alphonse, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1856-1856
Open Access | Times Cited: 7
Scaffold hopping for designing of potent and selective CYP1B1 inhibitors to overcome docetaxel resistance: synthesis and evaluation
Baddipadige Raju, Gera Narendra, Himanshu Verma, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-19
Closed Access | Times Cited: 2
Development of Novel N-Aryl-2,4-bithiazole-2-amine-Based CYP1B1 Degraders for Reversing Drug Resistance
Xiaoxuan Yao, Jianping Mao, Haoyu Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116488-116488
Closed Access | Times Cited: 2
Synthesis and evaluation of novel tetrahydroisoquinoline-benzo[h]chromen-4-one conjugates as dual ABCB1/CYP1B1 inhibitors for overcoming MDR in cancer
Jinyun Dong, Yulong Li, Zhiyuan Jin, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 114, pp. 117944-117944
Closed Access | Times Cited: 2
New Perspectives of CYP1B1 Inhibitors in the Light of Molecular Studies
Renata Mikstacka, Zbigniew Dutkiewicz
Processes (2021) Vol. 9, Iss. 5, pp. 817-817
Open Access | Times Cited: 19
Excited state intramolecular proton transfer of 2-phenyl,3-hydroxybenzo[g]quinolones in solution and in G4 supramolecular hydrogels
Sourav Dutta, Debabrata Mandal
Journal of Molecular Liquids (2022) Vol. 361, pp. 119651-119651
Closed Access | Times Cited: 10
Recent developments of P-glycoprotein inhibitors and its structure–activity relationship (SAR) studies
Xuanming Zhao, Jing Di, Dingjie Luo, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 106997-106997
Closed Access | Times Cited: 5
Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review
Baddipadige Raju, Shalki Choudhary, Gera Narendra, et al.
Drug Metabolism Reviews (2021) Vol. 53, Iss. 1, pp. 45-75
Closed Access | Times Cited: 13
Anticancer activity and evaluation of apoptotic genes expression of 2-azetidinones containing anthraquinone moiety
Masoud Mohamadzadeh, Maaroof Zarei
Molecular Diversity (2020) Vol. 25, Iss. 4, pp. 2429-2439
Closed Access | Times Cited: 13
3D-QSAR assisted identification of selective CYP1B1 inhibitors: an effective bioisosteric replacement/molecular docking/electrostatic complementarity analysis
Baddipadige Raju, Bharti Sapra, Om Silakari
Molecular Diversity (2022) Vol. 27, Iss. 6, pp. 2673-2693
Closed Access | Times Cited: 4
Chalcones: Potential Anticancer Agents
Adam McCluskey, Cecilia C. Russell
IntechOpen eBooks (2021)
Open Access | Times Cited: 5
Translational Research in Cancer
Sivapatham Sundaresan, Yeunhwa Gu, Hwa Gu, et al.
IntechOpen eBooks (2019)
Open Access | Times Cited: 5
In silico guided designing of optimized benzochalcones derivatives as potent CYP1B1 inhibitors: An integrated in vitro and ONIOM study
Himani Sharma, Baddipadige Raju, Gera Narendra, et al.
Journal of Molecular Graphics and Modelling (2022) Vol. 119, pp. 108390-108390
Closed Access | Times Cited: 3
A new class of CYP1B1 inhibitors derived from bentranil
Lan Yi, Xinyue Huang, Meixian Yang, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 80, pp. 129112-129112
Closed Access | Times Cited: 3
Current perspectives on benzoflavone analogues with potent biological activities: A review
Guangxin Liu, Zefeng Zhao, Mengjia Li, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 9, pp. 104109-104109
Open Access | Times Cited: 1

Ahmed Mahmood
Science Archives (2022) Vol. 03, Iss. 04
Open Access
Page 1

Scroll to top